May 10, 2004 – Womenâ€™s rights groups expressed outrage Friday at the Federal Drug Administrationâ€™s (FDA) decision to reject an application for over-the-counter sales of an emergency contraceptive. The FDA clarified that Barr Laboratories, the company that makes the Plan B contraceptive, could resubmit its application, if the company can provide more data about the drugâ€™s safety for young women or if it can design a way to sell the drug over-the-counter only for women over the age of sixteen. The agency said it turned down the application because Barr did not provide enough data about the drugâ€™s safety for young women. But womenâ€™s rights groups and many health experts accuse the FDA of caving in to pressure from conservative Republican lawmakers and fundamentalist womenâ€™s groups. The FDAâ€™s own advisory panel, after reviewing research on the drugâ€™s safety, had recommended overwhelmingly in December that to agency approve over-the-counter sales of Plan B without restrictions. Numerous drugs have been approved by the FDA for over-the-counter sales with even less information on child safety. Advocates of Plan B, including doctorâ€™s groups, predict making the drug easier to access could drastically reduce the number of unintended pregnancies in the US.